Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 13, 2026 3.453
November 12, 2026 3.423
November 11, 2026 3.620
November 10, 2026 3.606
November 09, 2026 3.747
November 06, 2026 3.636
November 05, 2026 3.493
November 04, 2026 3.731
November 03, 2026 3.632
November 02, 2026 3.481
October 30, 2026 3.358
October 29, 2026 3.429
October 28, 2026 3.417
October 27, 2026 3.409
October 26, 2026 3.163
October 23, 2026 3.143
October 22, 2026 3.173
October 21, 2026 3.234
October 20, 2026 3.274
October 19, 2026 3.065
October 16, 2026 2.868
October 15, 2026 3.077
October 14, 2026 3.026
October 13, 2026 3.079
October 12, 2026 3.212
Date Value
October 09, 2026 3.348
October 08, 2026 3.294
October 07, 2026 3.214
October 06, 2026 3.099
October 05, 2026 3.107
October 02, 2026 3.059
October 01, 2026 3.183
September 30, 2026 3.242
September 29, 2026 3.825
September 28, 2026 3.855
September 25, 2026 3.782
September 24, 2026 3.896
September 23, 2026 3.829
September 22, 2026 4.044
September 21, 2026 4.039
September 18, 2026 4.037
September 17, 2026 4.261
September 16, 2026 4.083
September 15, 2026 4.224
September 14, 2026 4.370
September 11, 2026 4.297
September 10, 2026 4.346
September 09, 2026 4.528
September 08, 2026 4.792
September 04, 2026 5.729

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.57
Anika Therapeutics, Inc. 1.266
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.476

Price to Book Value Related Metrics

Price 16.62
Earnings Yield -21.88%
Market Cap 3.112B